Nanotechnology Now - Press Release: Nanotech, Megamillions: Fortune, Fame, Failures, & Folly--A Contrarian View from a Venture Capital Investor

Home > Press > Nanotech, Megamillions: Fortune, Fame, Failures, & Folly--A Contrarian View from a Venture Capital Investor

Abstract:
The best way to make a fortune from the future is to predict it. And the best way to predict the future is to invent it.

Nanotech, Megamillions: Fortune, Fame, Failures, & Folly--A Contrarian View from a Venture Capital Investor

San Diego, CA | Posted on March 23rd, 2009

From the PC boom to the Biotech boom to the Telecom & Internet boom, now find out why scientists, entrepreneurs, venture capital investors, big corporations and governments around the world are investing time and money in emerging technologies like nanotech--widely considered the "next industrial revolution". From the mundane to the magnificent: Which products are on the market already? What breathtaking breakthroughs should you expect coming in the years? Which companies are leading the pack? Who are the entrepreneurs that may turn out to be the next Bill Gates, Steve Jobs or Michael Dell. What are the over hyped and under hyped areas of nanotech? Who will go bust? What new capabilities come especially at the nanoscale? How will manufacturing with atomic-level precision change the economics of manufacturing? How will nanotech impact the "green economy" from batteries in electric cars to cleaning up nuclear waste? Join us for this exciting program featuring exclusive insights from a leading investor in over 15 cutting-edge nanotech companies located all over the world.

Distinguished Speaker:
Josh Wolfe, Co-Founder and Managing Partner, Lux Capital

Wednesday, April 1, 2009
5:30-8:30p.m

About the Event, Agenda, and Venue - Celebrate Science with us!

5:30p - Reception, Demos and networking
6:30p - Program starts
7:45p - Dessert and more demos

In support of the San Diego Science Festival, the event kicks off with a very special 'Nanotech Mashup' reception. A unique opportunity for the community to meet top notch nanotech scientists and industry experts in a relaxed setting. The reception also features an array of hands-on demonstrations, videos and educational material to help you learn about these innovative technologies and how they address some of hte world's toughest challenges from medicine to energy.

####

About NanoTecNexus
History: Founded in 2004, NanoTecNexus (formerly known as NanoBioNexus) has grown to be the premier nanotechnology industry organization that showcases the latest nanotechnology research with a special interest in life sciences. Headquartered in San Diego, California and with offices in Tucson AZ, San Jose California and Vancouver WA, NanoTecNexus and its affiliate University Chapters provide regular forums that present relevant nanotechnologies and discusses the impact and opportunities for industry professionals, academics, commercial companies and investors. Issues and challenges vital to this emerging field are also examined with scientific experts and industry pundits.

Mission: To catalyze collaboration and knowledge exchange in the nanotech field by connecting people, technology, investment and industry. This is accomplished through educational initiatives, forums, seminars and courses as well as leading market research that provide heightened visibility into scientific breakthroughs in the nanobio field and beyond.

Goal: To promote safe and market accepted advances in nanoscience that maximize societal benefits through new products and applications.

Vision: To be the most essential industry organization and be recognized as the leading organization of economic observers and business arbiters dedicated to the nanotechnology field with special interest in life sciences.

About Josh Wolfe, Co-Founder and Managing Partner, Lux Capital

Josh is a Co-Founder and Managing Partner of Lux Capital, focusing on investments in nanotechnology, semiconductors and life sciences. Josh manages Lux Capital's investments in Nanosys and Cambrios, and serves on the Board of Directors of Crystal IS and Lux Research. Before forming Lux Capital, he worked in Salomon Smith Barney's Investment Banking group, where his experience included a $4 billion hotel merger and a defense against an unsolicited LBO. Josh has also worked in capital markets while at Merrill Lynch on its Financial Futures & Options/Government Strategy desk and at Prudential Securities in its Municpal Finance department. Prior to venturing into the financial world, Josh conducted and published cutting-edge AIDS/immunopathology research in Cell Vision and The Journal of Leukocyte Biology, leading medical/immunology journals. Josh graduated with distinction from Cornell University with a B.S. in Economics and Finance. He has been an invited guest speaker, lecturer, and panelists on nanotechnology for CNBC, CNN, Harvard, Yale, Wharton, Columbia, Cornell, Merrill Lynch, Credit Suisse First Boston, Capital Hill, government labs, and officials in France, Canada, UK, Spain, Singapore, and Germany. Widely recognized as one of the preeminent minds in nanotechnology and finance, Josh has been invited by the White House and Canadian Government to advise government organizations on funding strategies. Josh is co-founder of The NanoBusiness Alliance, a columnist with Forbes Magazine and Editor of the monthly Forbes/Wolfe Emerging Tech Report.

For more information, please click here

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: